🔗 Permalink

Inventor profile of:

Andreas Meinke

City:

Pressbaum

Country:

Austria

Published Applications:

Last publication date:

2025-07-03

Top Assignees for applications by Andreas Meinke

The entities that hold a legal rights for patent applications filed by inventor Meinke Andreas:

Intercell AG 42 Vienna, Austria
Valneva Austria GmbH 21 Vienna, Austria
Valneva SE 7 Nantes, France
Intercell Austria AG 3 Vienna, Austria
Dynavax Technologies Corporation 2 Emeryville, CA United States
Valneva SE 2 Saint-Herblain, France
INTERCELL AG 2 VIENNA, Australia

Recent patent applications by Meinke Andreas

Andreas Meinke from Pressbaum, AT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-07-03

US20250213667A1

Human necessities

CLOSTRIDIUM DIFFICILE VACCINE

#2 | 2025-05-29

US20250171501A1

Chemistry; metallurgy

A SUBUNIT VACCINE FOR TREATMENT OR PREVENTION OF A RESPIRATORY TRACT INFECTION

#3 | 2025-03-27

US20250101069A1

Chemistry; metallurgy

MULTIVALENT OSPA POLYPEPTIDES AND METHODS AND USES RELATING THERETO

#4 | 2025-03-06

US20250073326A1

Human necessities

METHOD OF PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING IMMUNOGENIC CHIKUNGUNYA VIRUS CHIKV-DELTA5NSP3

#5 | 2024-10-31

US20240358812A1

Human necessities

HUMAN METAPNEUMOVIRUS COMBINATION VACCINE

#6 | 2024-09-05

US20240293531A1

Human necessities

INACTIVATED SARS-COV-2 VIRUS VACCINE

#7 | 2024-02-29

US20240067681A1

Chemistry; metallurgy

Subunit vaccine for treatment or prevention of a respiratory tract infection

#8 | 2023-09-21

US20230295245A1

Chemistry; metallurgy

MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO

#9 | 2023-09-21

US20230293661A1

Human necessities

Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3

#10 | 2023-05-18

US20230151063A1

Chemistry; metallurgy

Multivalent OspA polypeptides and methods and uses relating thereto

#11 | 2023-03-23

US20230092650A1

Human necessities

CORONAVIRUS VACCINES COMPRISING A TLR9 AGONIST

#12 | 2023-02-09

US20230038284A1

Human necessities

CpG-adjuvanted SARS-CoV-2 virus vaccine

#13 | 2022-06-16

US20220185851A1

Chemistry; metallurgy

Mutant fragments of OspA and methods and uses relating thereto

#14 | 2022-06-16

US20220185847A1

Chemistry; metallurgy

Subunit vaccine for treatment or prevention of a respiratory tract infection

#15 | 2022-01-20

US20220016230A1

Human necessities

Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3

#16 | 2021-10-21

US20210322534A1

Human necessities

Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3

#17 | 2020-07-30

US20200239525A1

Chemistry; metallurgy

Mutant fragments of OspA and methods and uses relating thereto

#18 | 2018-11-15

US20180327460A1

Chemistry; metallurgy

Mutant fragments of OspA and methods and uses relating thereto

#19 | 2017-04-20

US20170107263A1

Chemistry; metallurgy

Mutant fragments of OspA and methods and uses relating thereto

#20 | 2017-04-13

US20170101446A1

Chemistry; metallurgy

Mutant fragments of OspA and methods and uses relating thereto

#21 | 2015-09-10

US20150250865A1

Human necessities

MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO

#22 | 2015-08-20

US20150232517A1

Chemistry; metallurgy

MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO

#23 | 2014-07-31

US20140212448A1

Chemistry; metallurgy

KLEBSIELLA ANTIGENS

#24 | 2014-01-16

US20140017270A1

Chemistry; metallurgy

SMALL STREPTOCOCCUS PYOGENES ANTIGENS AND THEIR USE

#25 | 2014-01-09

US20140010835A1

Chemistry; metallurgy

Mutant fragments of OspA and methods and uses relating thereto

#26 | 2013-12-05

US20130323256A1

Chemistry; metallurgy

antigens I and II

#27 | 2013-10-31

US20130287782A1

Chemistry; metallurgy

ENTEROCOCCUS ANTIGENS

#28 | 2013-10-24

US20130280288A1

Human necessities

PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE AND COMPOSITIONS, METHODS AND USES RELATING THERETO

#29 | 2013-09-19

US20130243779A1

Chemistry; metallurgy

PEPTIDES PROTECTIVE AGAINST E. FAECALIS, METHODS AND USES RELATING THERETO

#30 | 2013-09-05

US20130230526A9

Chemistry; metallurgy

KLEBSIELLA ANTIGENS

#31 | 2013-05-30

US20130136761A1

Chemistry; metallurgy

S. PNEUMONIAE ANTIGENS

#32 | 2013-05-16

US20130122047A1

Human necessities

STREPTOCOCCUS PYOGENES ANTIGENS

#33 | 2013-05-16

US20130122030A1

Human necessities

S. EPIDERMIDIS ANTIGENS

#34 | 2013-05-09

US20130116406A1

Chemistry; metallurgy

BORRELIA ANTIGENS

#35 | 2013-04-25

US20130101613A1

Human necessities

Protective proteins of , combinations thereof and methods of using the same

#36 | 2013-02-07

US20130034575A1

Chemistry; metallurgy

Method for identification, isolation and production of antigens to a specific pathogen

#37 | 2013-01-10

US20130011403A1

Chemistry; metallurgy

antigens

#38 | 2012-11-22

US20120294881A1

Human necessities

Peptides protective against and compositions, methods and uses relating thereto

#39 | 2012-10-25

US20120269843A1

Human necessities

S. epidermidis antigens

#40 | 2012-07-19

US20120184710A1

Chemistry; metallurgy

antigens

#41 | 2012-06-07

US20120141487A1

Chemistry; metallurgy

MORAXELLA CATARRHALIS ANTIGENS

#42 | 2012-04-05

US20120082674A1

Chemistry; metallurgy

antigens

#43 | 2012-02-23

US20120045457A1

Chemistry; metallurgy

Nontypable antigens

#44 | 2011-11-24

US20110287013A1

Chemistry; metallurgy

Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof

#45 | 2011-10-06

US20110243978A1

Chemistry; metallurgy

Enterococcus antigens

#46 | 2011-09-29

US20110236410A1

Chemistry; metallurgy

antigens

#47 | 2011-06-30

US20110159027A1

Chemistry; metallurgy

antigens I and II

#48 | 2011-04-21

US20110091494A1

Human necessities

Peptides protective against and compositions, methods and uses relating thereto

#49 | 2011-01-27

US20110020402A1

Chemistry; metallurgy

Method for identification, isolation and production of antigens to a specific pathogen

#50 | 2010-12-23

US20100323003A1

Chemistry; metallurgy

Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines

#51 | 2010-11-25

US20100297162A1

Human necessities

antigens

#52 | 2010-10-14

US20100260790A1

Chemistry; metallurgy

antigens

#53 | 2010-10-07

US20100255034A1

Human necessities

antigens

#54 | 2010-09-02

US20100221277A1

Chemistry; metallurgy

CHLAMYDIA PNEUMONIAE ANTIGENS

#55 | 2010-08-12

US20100203075A1

Chemistry; metallurgy

CHLAMYDIA ANTIGENS

#56 | 2010-07-01

US20100166732A1

Chemistry; metallurgy

Small antigens and their use

#57 | 2010-06-03

US20100136039A1

Chemistry; metallurgy

antigens

#58 | 2010-05-27

US20100129388A1

Human necessities

Protective proteins of , combinations thereof and methods of using the same

#59 | 2010-05-06

US20100113340A1

Chemistry; metallurgy

Nucleic acids coding for adhesion factor of group B , adhesion factors of group B and further uses thereof

#60 | 2009-03-05

US20090060934A1

Chemistry; metallurgy

antigens I and II

#61 | 2008-07-24

US20080175856A1

Chemistry; metallurgy

Enterococcus Antigens

#62 | 2008-02-14

US20080038287A1

Chemistry; metallurgy

Method for identification, isolation and production of antigens to a specific pathogen

#63 | 2007-06-07

US20070128183A1

Chemistry; metallurgy

Td antigens

#64 | 2007-02-15

US20070036778A1

Human necessities

antigens

#65 | 2006-11-30

US20060269541A1

Chemistry; metallurgy

antigens I + II

#66 | 2006-11-23

US20060263846A1

Chemistry; metallurgy

antigens

#67 | 2006-10-26

US20060240029A1

Chemistry; metallurgy

Chlamydia pneumoniae antigens

#68 | 2006-08-31

US20060194751A1

Human necessities

Streptococcus pyogene antigens

#69 | 2006-06-01

US20060115479A1

Chemistry; metallurgy

Nucleic acids coding for adhesion factor of group B , adhesion factors of group B and further uses thereof

#70 | 2005-02-17

US20050037444A1

Chemistry; metallurgy

Method for identification, isolation and production of antigens to a specific pathogen

InventorID:

27055 ⎘